Michael Ryskin

Stock Analyst at B of A Securities

(1.37)
# 3,340
Out of 4,847 analysts
35
Total ratings
47.83%
Success rate
-5.04%
Average return

Stocks Rated by Michael Ryskin

Tempus AI
May 20, 2025
Maintains: Neutral
Price Target: $48$68
Current: $61.96
Upside: +9.75%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9$8
Current: $2.23
Upside: +258.74%
IDEXX Laboratories
Feb 4, 2025
Maintains: Neutral
Price Target: $475$535
Current: $525.83
Upside: +1.74%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200$206
Current: $179.16
Upside: +14.98%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28$40
Current: $45.79
Upside: -12.64%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10$9.5
Current: $5.43
Upside: +74.95%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27$24
Current: $11.46
Upside: +109.42%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27$24
Current: $13.15
Upside: +82.51%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225$180
Current: $170.30
Upside: +5.70%
Recursion Pharmaceuticals
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.39
Upside: -
Downgrades: Neutral
Price Target: $80$52
Current: $22.90
Upside: +127.07%
Downgrades: Underperform
Price Target: $17$10
Current: $2.78
Upside: +259.71%